Digital Health Monitoring for Primary Biliary Cholangitis
Part of Digestive system, Skin clinical trials.
This study uses a smartphone app or digital platform to track how you're feeling day-to-day if you have primary biliary cholangitis (PBC), a liver condition where your immune system damages bile ducts. Researchers want to see if this digital monitoring helps them better understand and manage PBC symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary biliary cholangitis (PBC) based on blood tests, antibody tests, or a liver biopsy
- You have an elevated alkaline phosphatase level (an enzyme in your blood that signals liver stress)
- You are able to understand and sign a consent form
- You can complete digital questionnaires on a phone, tablet, or computer
- You do not have active cancer being treated right now
- You do not have another severe, uncontrolled inflammatory condition that causes fatigue or sleep problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study tracks how well Primary Biliary Cholangitis (PBC) responds to standard medication (UDCA) and what happens to patients' health over time. It may help doctors understand which treatments work best for different people.
This study tracks patients with primary biliary cholangitis (PBC) over time to understand long-term outcomes. It aims to gather information that could improve care and management for people with PBC.
This trial tests a program of exercise, nutrition, and education to help reduce fatigue in people with primary biliary cholangitis. It aims to see if this program can improve energy and quality of life.
This study looks for early signs of Primary Biliary Cholangitis in people who have a positive AMA blood test but normal liver enzyme levels. It aims to find the disease before it causes symptoms.
This trial tests adding prednisone (a steroid) to ursodeoxycholic acid (a bile acid medicine) for people with primary biliary cholangitis who have a specific type of liver inflammation. The goal is to see if the combination works better at controlling the disease than standard care.
This study observes people with primary biliary cholangitis (PBC) to learn more about the disease and what factors might make it worse over time. It uses your medical history and liver biopsy results to understand how PBC progresses.
Hear when a new Primary Biliary Cholangitis (PBC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.